Tin tức & Cập nhật

Treatment with levothyroxine does not yield clear effects on cardiometabolic biomarkers in older adults with subclinical hypothyroidism, according to a study. However, individuals with baseline thyroid-stimulating hormone (TSH) ≥10 mIU/L show potentially favourable changes in lipids and lipoproteins.

In the phase III SUNRISE trial, tezepelumab significantly reduces daily maintenance oral corticosteroid (OCS) dose while maintaining asthma control in adults with severe OCS-dependent asthma, despite early study termination and the smaller-than-planned sample size.